Start for free
Start for free
Penn Medicine Co-Investment Program logo

Penn Medicine Co-Investment Program

North America, Pennsylvania, United States, Philadelphia

Description

Penn Medicine Co-Investment Program is funding platform for cell and gene therapy, mRNA, lipid nanoparticle, and health technologies.

Investor Profile

Penn Medicine Co-Investment Program has made 14 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (36%)
  • Series B (29%)
  • Seed (21%)
  • Series C (7%)
  • Series Unknown (7%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Genetics
  • Manufacturing
  • Life Science
  • Biopharma
  • Robotics
  • Bioinformatics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Penn Medicine Co-Investment Program frequently co-invest with?

Wellington Partners
Wellington Partners
Europe, Bayern, Germany, Munich
Co-Investments: 3
The Mark Foundation for Cancer Research
The Mark Foundation for Cancer Research
North America, New York, United States, New York
Co-Investments: 2
Agent Capital
Agent Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 6
MRL Ventures Fund
MRL Ventures Fund
North America, Massachusetts, United States, Cambridge
Co-Investments: 3
Tellus BioVentures
Tellus BioVentures
North America, New York, United States, Florida
Co-Investments: 3
BrightEdge Fund
BrightEdge Fund
North America, Georgia, United States, Atlanta
Co-Investments: 2
TPG Biotech
TPG Biotech
North America, California, United States, San Francisco
Co-Investments: 3
HealthCap
HealthCap
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 3
IP Group
IP Group
Europe, England, United Kingdom, London
Co-Investments: 3
University of Pennsylvania
University of Pennsylvania
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 2

Which angels does Penn Medicine Co-Investment Program often collaborate with?

BA
Bruce A. Peacock
North America, Maryland, United States, Baltimore
Shared Deals: 1

What are some of recent deals done by Penn Medicine Co-Investment Program?

Carisma Therapeutics

Philadelphia, Pennsylvania, United States

Carisma Therapeutics is a biotech company that develops novel chimeric antigen receptor macrophage technology to treat solid tumors.

BiotechnologyHealth CareLife ScienceMedicalTherapeutics
Series CSep 21, 2022
Amount Raised: $30,000,000
Innervace

Philadelphia, Pennsylvania, United States

Innvervace develops regenerative therapy solutions for neurodegenerative disorders.

BiotechnologyHealth CareMedicalNeuroscience
Series ASep 8, 2022
Amount Raised: $40,000,000
Vittoria Biotherapeutics

Philadelphia, Pennsylvania, United States

Vittoria Biotherapeutics is a gene-edited cell therapeutics company.

BioinformaticsBiotechnologyTest and Measurement
SeedJun 7, 2022
Amount Raised: $10,000,000
CareAlign

Philadelphia, Pennsylvania, United States

CareAlign provides clinicians with an intuitive, patient-centric task management tool to track, manage and coordinate clinical care.

Developer ToolsHealth CareSoftware
SeedNov 30, 2021
Amount Raised: $2,300,000
Interius BioTherapeutics

Philadelphia, Pennsylvania, United States

Interius BioTherapeutics is a biopharmaceutical company that develops in vivo cell-specific gene medicines to treat B cell lymphomas.

BiopharmaBiotechnologyHealth CareTherapeutics
Series AMay 18, 2021
Amount Raised: $76,000,000
Carisma Therapeutics

Philadelphia, Pennsylvania, United States

Carisma Therapeutics is a biotech company that develops novel chimeric antigen receptor macrophage technology to treat solid tumors.

BiotechnologyHealth CareLife ScienceMedicalTherapeutics
Series BMar 1, 2021
Amount Raised: $12,000,000
Interius BioTherapeutics

Philadelphia, Pennsylvania, United States

Interius BioTherapeutics is a biopharmaceutical company that develops in vivo cell-specific gene medicines to treat B cell lymphomas.

BiopharmaBiotechnologyHealth CareTherapeutics
SeedMar 13, 2020
Amount Raised: $5,500,000
Tmunity Therapeutics

Philadelphia, Pennsylvania, United States

Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells.

BiotechnologyGeneticsHealth CareManufacturingTherapeutics
Series BOct 31, 2019
Amount Raised: $75,000,000
Linnaeus Therapeutics

Haddonfield, New Jersey, United States

Linnaeus Therapeutics is a development stage biotech company that develops and commercializes drugs for cancer.

BiotechnologyHealth CareMedicalTherapeutics
Series BSep 17, 2019
Amount Raised: $12,000,000
Cabaletta Bio

Philadelphia, Pennsylvania, United States

Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.

BiotechnologyHealth CareMedicalRoboticsTherapeutics
Series BJan 3, 2019
Amount Raised: $50,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator